Barclays cuts Pinduoduo stock rating on China weakness, Temu losses By Investing.com

Barclays downgraded Pinduoduo to Equalweight from Overweight and cut its price target to $89 from $165, citing weaker-than-expected China core business and pressure on monetization from regulators. The company’s latest quarter was mixed, with revenue up 11% year over year to RMB106.2 billion but adjusted net profit down 17% due partly to a Rmb2 billion investment loss. Analysts remain divided, with several firms lowering targets on softer earnings, while Temu growth is re-accelerating but may remain loss-making near term.

Analysis

The market is starting to price PDD less like a structural compounder and more like a two-engine story where one engine is weakening while the other is still subsidized. The key second-order issue is that Temu’s re-acceleration does not translate cleanly into equity value if the offshore arm remains cash-burning and increasingly exposed to trade policy and platform-specific tariff scrutiny; in that case, the foreign growth story can become a capital drain that masks deterioration in the core cash generator.

The more important medium-term risk is margin compression in China from both regulation and internal product strategy. If merchant monetization normalizes downward while private label expands, PDD risks cannibalizing its own marketplace economics: it may preserve GMV, but each incremental yuan of GMV is less valuable if take rates fall and seller economics weaken. That combination can create a slow-burn multiple de-rating over the next 2-4 quarters even if headline revenue still grows low double digits.

Consensus may be underestimating how quickly analyst target cuts can feed into systematic selling and factor underweighting. A name that has already approached the low end of its 52-week range with a sharply lower earnings revision trend becomes vulnerable to further de-grossing, especially if management signals continued merchant support or Temu expansion spending. The contrarian bull case is that the stock is now discounting a durable impairment in China, so any stabilization in take rates or better-than-feared Temu loss trajectory could trigger a sharp bear squeeze from oversold levels.

Key Decisions for Investors

• Short PDD on rallies over the next 1-3 weeks; favor entry on any rebound toward prior support near the low-90s. Risk/reward is attractive if the market continues to mark down China monetization and Temu cash burn, with downside to the low-80s potentially extending if estimates are revised again.
• Pair trade: long BABA / short PDD for 1-3 months. BABA has a cleaner domestic commerce monetization story and more identifiable catalyst path, while PDD faces self-inflicted margin pressure from merchant support and private label overlap.
• Buy PDD downside via put spreads into any strength; target 1-2 quarter horizon. A 3-6 month 85/70 put spread offers defined risk if further analyst downgrades or guidance cuts drive another leg lower.
• For existing longs, reduce exposure and wait for evidence of take-rate stabilization before re-entering. The stock can stay cheap longer than expected if the core China business keeps under-earning while international losses persist.